Th17, Treg, IFN, TLR, NF-B Reporter Cell Lines for drug discovery screening

IMGENEX’s proprietary Reporter Cell Lines provide the most advanced system available for screening Treg, Th17, TLR, STAT3 and inflammatory pathway mediators.


IMGENEX Corp.
 
IMGENEX's proprietary Reporter Cell Lines provide the mostadvanced system available for screening Treg, Th17, TLR, STAT3 and inflammatorypathway mediators. New and unique LUCPorter Stable Reporter Cell lines includepromoters for IL-17A, ROR, ROR(t), FoxP3, IL-8, TLR3/IFN, STAT3, Ap-1 andCXCL2 as targets driving Renilla Luciferase reporter gene expression. 
 
IMGENEX Corp.
info@imgenex.com 
 


Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Front Cover

Latest Issue  

• Volume 18 • Issue 12 • December 2022/January 2023

December 2022/January 2023

December 2022/January 2023 issue